David Bowen
Impact in
- Hematology top 0.02%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Chronic Myeloid Leukemia Treatments
- Genetics top 0.05%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
- Hematology 163
- Acute Myeloid Leukemia Research 158
- Chronic Myeloid Leukemia Treatments 17
- Multiple Myeloma Research and Treatments 13
- Genetics 70
- Myeloproliferative Neoplasms: Diagnosis and Treatment 40
- Hemoglobinopathies and Related Disorders 24
- Co-authors
- Alan K. Burnett (17 shared papers)Marion E. Frew (8 shared papers)David C. Linch (3 shared papers)Rosemary E. Gale (3 shared papers)Stephen E. Langabeer (4 shared papers)Panagiotis D. Kottaridis (3 shared papers)Keith Wheatley (8 shared papers)Anthony H. Goldstone (1 shared paper)
- Journals
- Blood (57 papers)British Journal of Haematology (32 papers)Nature Communications (12 papers)Leukemia Research (12 papers)Leukemia (11 papers)
- Partner nations
- United KingdomUnited StatesGermany
In The Last Decade
David Bowen
223 papers receiving 27.3k citations
David Bowen's Hit Papers
Peers
Comparison fields: 5 of 178
- Hematology 14.3k
- Genetics 6.9k
- Cancer Research 5.4k
- Molecular Biology 10.9k
- Oncology 3.5k
Countries citing papers authored by David Bowen
This map shows the geographic impact of David Bowen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Bowen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Bowen more than expected).
Fields of papers citing papers by David Bowen
This network shows the impact of papers produced by David Bowen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Bowen. The network helps show where David Bowen may publish in the future.
Co-authors
The 25 scholars most cited alongside David Bowen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 228 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Revised International Prognostic Scoring System for Myelodysplastic Syndromes Hit paper breakdown → | 2012 | 2463 |
| 2 | The repertoire of mutational signatures in human cancer Hit paper breakdown → | 2020 | 2339 |
| 3 | Pan-cancer analysis of whole genomes Hit paper breakdown → | 2020 | 2109 |
| 4 | Clinical and biological implications of driver mutations in myelodysplastic syndromes Hit paper breakdown → | 2013 | 1540 |
| 5 | Somatic CALR Mutations in Myeloproliferative Neoplasms with Nonmutated JAK2 Hit paper breakdown → | 2013 | 1461 |
| 6 | The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials Hit paper breakdown → | 2001 | 1328 |
| 7 | SomaticSF3B1Mutation in Myelodysplasia with Ring Sideroblasts Hit paper breakdown → | 2011 | 1036 |
| 8 | The evolutionary history of 2,658 cancers Hit paper breakdown → | 2020 | 705 |
| 9 | Patterns of somatic structural variation in human cancer genomes Hit paper breakdown → | 2020 | 550 |
| 10 | Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet Hit paper breakdown → | 2013 | 535 |
| 11 | Coexistence of LMPP-like and GMP-like Leukemia Stem Cells in Acute Myeloid Leukemia Hit paper breakdown → | 2011 | 525 |
| 12 | Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing Hit paper breakdown → | 2020 | 476 |
| 13 | 2015 | 425 | |
| 14 | 2011 | 424 | |
| 15 | Analyses of non-coding somatic drivers in 2,658 cancer whole genomes Hit paper breakdown → | 2020 | 419 |
| 16 | Luspatercept in Patients with Lower-Risk Myelodysplastic Syndromes Hit paper breakdown → | 2020 | 412 |
| 17 | 2011 | 410 | |
| 18 | Intubation Practices and Adverse Peri-intubation Events in Critically Ill Patients From 29 Countries Hit paper breakdown → | 2021 | 354 |
| 19 | 2020 | 317 | |
| 20 | 2015 | 309 |
About David Bowen
David Bowen is a scholar working on Hematology, Genetics, Emergency Medicine, Cancer Research and Public Health, Environmental and Occupational Health, having authored 228 papers that have together received 27.8k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (158 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (40 papers), Acute Lymphoblastic Leukemia research (31 papers), Hemoglobinopathies and Related Disorders (24 papers), Cancer Genomics and Diagnostics (19 papers), Hematological disorders and diagnostics (18 papers), Chronic Myeloid Leukemia Treatments (17 papers) and Multiple Myeloma Research and Treatments (13 papers). The work is most often cited by research in Hematology (14.3k citations), Genetics (6.9k citations), Cancer Research (5.4k citations), Molecular Biology (10.9k citations) and Oncology (3.5k citations). David Bowen has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Alan K. Burnett, Marion E. Frew, David C. Linch, Rosemary E. Gale, Stephen E. Langabeer, Panagiotis D. Kottaridis, Keith Wheatley, Anthony H. Goldstone, Helen M. Walker and G Harrison. Their work appears in journals such as Blood, British Journal of Haematology, Nature Communications, Leukemia Research and Leukemia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.